Filing metadata

Accession number
0001127602-24-016190
Form type
Form 4
Filer
BIOCRYST PHARMACEUTICALS INC
CIK
CIK 882796
Filed
May 22, 2024
Reporting period
May 20, 2024
Description
Insider transaction

Explore SEC Filings Hub